This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Apr;39(4):1012-3.

doi: 10.1128/AAC.39.4.1012.

Questionable susceptibility reporting in a multicenter trial

P O Gubbins, R W Bradsher

PMID: 7785972
PMCID: PMC162675
DOI: 10.1128/AAC.39.4.1012

Comment

Questionable susceptibility reporting in a multicenter trial

P O Gubbins et al. Antimicrob Agents Chemother. 1995 Apr.

. 1995 Apr;39(4):1012-3.

doi: 10.1128/AAC.39.4.1012.

Authors

P O Gubbins, R W Bradsher

PMID: 7785972
PMCID: PMC162675
DOI: 10.1128/AAC.39.4.1012

No abstract available

PubMed Disclaimer

Comment on

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Fink MP, Snydman DR, Niederman MS, Leeper KV Jr, Johnson RH, Heard SO, Wunderink RG, Caldwell JW, Schentag JJ, Siami GA, et al. Fink MP, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):547-57. doi: 10.1128/AAC.38.3.547. Antimicrob Agents Chemother. 1994. PMID: 8203853 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources